Management of heparin-induced thrombocytopenia

Author： Jaax Miriam E. Greinacher Andreas

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.13, Iss.7, 2012-05, pp. : 987-1006

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Lepirudin in the management of heparin-induced thrombocytopenia

By Gajra Ajeet Husain Juhi Smith Adrienne

Expert Opinion on Drug Metabolism and Toxicology, Vol. 4, Iss. 8, 2008-08 ,pp. : 1131-1141

Informa Healthcare

Access to resources Recommend Favorite

Pharmacotherapy of heparin-induced thrombocytopenia

By Dager William E White Richard H

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 6, 2003-06 ,pp. : 919-940

Informa Healthcare

Access to resources Recommend Favorite

Argatroban: A Review of its Use in the Management of Heparin-Induced Thrombocytopenia

By Dhillon Sohita

American Journal of Cardiovascular Drugs, Vol. 9, Iss. 4, 2009-08 ,pp. : 261-282

Adis International

Access to resources Recommend Favorite

Strategies for the Management of Suspected Heparin-Induced Thrombocytopenia: A Cost-Effectiveness Analysis

By Patrick Amanda R. Winkelmayer Wolfgang C. Avorn Jerry Fischer Michael A.

PharmacoEconomics, Vol. 25, Iss. 11, 2007-01 ,pp. : 949-961

Adis International

Access to resources Recommend Favorite

Management of Heparin‐Induced Thrombocytopenia During Renal Replacement Therapy

Hemodialysis International, Vol. 5, Iss. 1, 2001-01 ,pp. : 81-85

John Wiley & Sons Inc

Access to resources Recommend Favorite